Background: In autoimmune hepatitis (AIH), clinical practice and treatment guidelines frequently diverge as a reflection of disease heterogeneity and challenges in achieving standardised care. We sought to explore the utility of multiparametric (mp) MR in patients with AIH, and the impact of this technology on physicians’ decision making and intended patient management. Methods: 82 AIH patients, recruited from two sites between June and November 2019 as part of an observational cohort study, underwent non-contrast MRI alongside their standard clinical investigations.
This Article supprts SDGs 3 and 10 by assessing the performance of four severity scoring systems used for case-mix determination and benchmarking in intensive care units to identify possible ethnicity-based bias. The study found systemic differences in calibration across ethnicities.
